scispace - formally typeset
Open AccessJournal ArticleDOI

Neue Empfehlungen der STIKO zum Impfen im Alter

About
This article is published in Mmw-fortschritte Der Medizin.The article was published on 2021-05-01 and is currently open access. It has received 0 citations till now.

read more

Content maybe subject to copyright    Report

References
More filters
Journal ArticleDOI

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

TL;DR: The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older and was similar to that in the other two age groups.
Journal ArticleDOI

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Merryn Voysey, +766 more
- 06 Mar 2021 - 
TL;DR: The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4-12 weeks as discussed by the authors.
Journal ArticleDOI

A systematic review of SARS-CoV-2 vaccine candidates.

TL;DR: An overview of the experimental and clinical data obtained from recent SARS-CoV-2 vaccines trials are provided, and certain potential safety issues that require consideration when developing vaccines are highlighted.
Journal ArticleDOI

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

TL;DR: Quantitative-PCR and immunofluorescence staining results indicate that SARS-CoV is capable of replication in HL-CZ cells, and of displaying virus-induced cytopathic effects and increased levels of TNF-α, IL-4 and IL-6 two days post-infection, while data from infectivity assays indicate that antibodies against SARsCoV spike proteins may trigger ADE effects.